Feature | July 06, 2020

Most Popular Cardiology Technology Content in June 2020

This is the most popular cardiac technology news content from the past month according to reader pageview analytics

Three of the most popular cardiovascular technologies to make news in June 2020. Top is the Impella Expandable Cardiac Pump (ECP) that is about to enter U.S. feasibility trials.Bottom left, the Foldax heart valve uses a flexible man-made material for valve leaflets rather than animal pericardium tissue. The hope is this new type of surgical and transcatheter aortic valve replacements (TAVR) device will enhance longevity of the valve leaflets. Bottom right, the SMT Hydra TAVR valve is the first Indian-made s

Three of the most popular cardiovascular technologies to make the top news in June 2020. Top is the Impella Expandable Cardiac Pump (ECP) that is about to enter U.S. feasibility trials.Bottom left, the Foldax heart valve uses a flexible man-made material for valve leaflets rather than animal pericardium tissue. The hope is this new type of surgical and transcatheter aortic valve replacements (TAVR) device will enhance longevity of the valve leaflets. Bottom right, the SMT Hydra TAVR valve is the first Indian-made structural heart devices to gain European CE mark approval.

July 6, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of June 2020. This is based on the website’s 267,198 pageviews for the month. While COVID-19 topics still are among the popular topics on the list, there has been a noticable return to normal reader interest in new cardiovascular technologies.
 

1. Kawasaki-like Inflammatory Disease Affects Children With COVID-19

2. The Cardiovascular Impact of COVID-19

3. FDA Approves First-in-Human Trial of Impella ECP, World’s Smallest Heart Pump

4. New Technologies Take Cardiac CT to the Next Level

5. SMT Hydra TAVR System Receives European CE Mark Approval

6. Foldax Gets $20 Million to Finance Innovative Heart Valve Technology

7. ASE Guidelines for the Protection of Echocardiography Providers During the COVID-19 Outbreak

8. Impella RP Granted FDA Emergency Use Authorization for COVID-19 Patients With Right Heart Failure

9. FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine for COVID-19

10. First Implantation of Carmat Total Artificial Heart in Denmark 

11. Pulsed Field Ablation Successfully Treats Atrial Fibrillation

12. FDA Grants Breakthrough Device Designation for preCardia Catheter-based Heart Failure Treatment

13. New Heart Failure Devices and Drugs to Treat Heart Failure

14. WHO Database Shows Serious Health Impact of Hydroxychloroquine and Azithromycin Being Used to Treat COVID-19

15. New Guideline Outlines Use of Transesophageal Echo to Assist Surgical Decision-making 

16. Use of Ultrasound to Improve Vascular Access

17. VIDEO: Demonstration of Abiomed Impella ECP 9 French Transcatheter Ventricular Assist Device

18. FDA Clears Scoring Sheath That Fits Over Standard Angioplasty Balloons

19. VIDEO: Top New EP Technologies at Heart Rhythm Society 2020

20. New Data Confirms Majority of Americans Avoiding Treatment for Heart Attack and Stroke Due to COVID-19

21. Edwards Pascal Tricuspid Valve Transcatheter Repair System Approved in Europe

22. Biotronik Launches His-Bundle Pacing Tools

23. Heart Rhythm Society 2020 Late-Breaking Clinical Trials in Electrophysiology

24. Cardiac Imaging Best Practices During the COVID-19 Pandemic 

25. COVID-19 Genetic PCR Tests Give False Negative Results if Used Too Early
 

Related Popular Cardiology Content:

Most Popular Cardiology Technology Content in May 2020

Most Popular Cardiology Technology Content in March 2020

Most Popular Cardiology Technology Content in February 2020

Most Popular Cardiology Technology Content in January 2020

Top 25 Cardiology Videos on DAIC in 2019

The Most Popular Cardiology Topics in 2019

Most Popular Cardiology Technology Content in November 2019

Related Content

The Keystone Heart TriGuard 3 (TG3) is a self-stabilizing cerebral embolic deflection filter used in patients undergoing transcatheter aortic valve replacement (TAVR). The device is designed to reduce TAVR complications of cerebral embolization and ischemic stroke. #TCT #TCT2020 #TCTconnect

The Keystone Heart TriGuard 3 (TG3) is a self-stabilizing cerebral embolic deflection filter used in patients undergoing transcatheter aortic valve replacement (TAVR). The device is designed to reduce TAVR complications of cerebral embolization and ischemic stroke. 

News | Heart Valve Technology | October 15, 2020
October 15, 2020 – The REFLECT II randomized clinical trial evaluating the safety and efficacy of the Keystone Heart
The Boston Scientific Acurate neo self-expanding TAVR valve (left) did not perform as well clinically as the Medtronic CoreValve Evolut TAVR valve (right) in the SCOPE II trial presented at TCT 2020. #TCT #TCT2020 #TCTconnect

The Boston Scientific Acurate neo self-expanding TAVR valve (left) did not perform as well clinically as the Medtronic CoreValve Evolut TAVR valve (right) in the SCOPE II trial presented at TCT 2020.

Feature | Heart Valve Technology | October 15, 2020
October 15, 2020 – The SCOPE II trial comparing the Boston Scientific Acurate neo vs.
An illustration showing the MitraClip catheter entering the left atrium through a transseptal puncture. #TCT2020 #TCTconnect

An illustration showing the MitraClip catheter entering the left atrium through a transseptal puncture.

News | Heart Valve Technology | October 15, 2020
October 15, 2020 – The...
Medtronic is starting a randomized, head-to-head study comparing the Medtronic CoreValve Evolut Pro and Pro+TAVR Systems against the balloon-expandable Edwards Sapien 3 and Sapien 3 Ultra Transcatheter Heart Valvestwo transcatheter aortic valve replacement (TAVR) systems in patients with severe symptomatic aortic stenosis (ssAS). 

Medtronic is starting a randomized, head-to-head study comparing the Medtronic CoreValve Evolut Pro and Pro+TAVR Systems against the balloon-expandable Edwards Sapien 3 and Sapien 3 Ultra Transcatheter Heart Valvestwo transcatheter aortic valve replacement (TAVR) systems in patients with severe symptomatic aortic stenosis (ssAS). 

News | Heart Valve Technology | October 14, 2020
October 14, 2020 — Medtronic announced it is starting a randomized, head-to-head study comparing two transcatheter ao
The Cardiac Dimensions Carillon Mitral Contour System, a transcatheter device used to treat functional mitral regurgitation (FMR) in patients with heart failure.
News | Heart Valve Technology | October 02, 2020
October 2, 2020 — Cardiac Dimensions announced the company has closed a $17.5 million Series C financing that will be
Boston Scientific launched the Acurate neo2 transcatheter aortic valve replacement (TAVR) system in Europe. This next-generation transcatheter aortic valve implantation (TAVI) technology is a new platform designed with a number of features to improve upon the clinical performance of the original Acurate neo platform. Compared to the previous generation device, the Acurate neo2 valve system also has an expanded indication for patients with aortic stenosis. #TAVR #TAVI
News | Heart Valve Technology | September 29, 2020
September 29, 2020 — Boston Scientific launched the...
National Survey Of Heart Valve Patients Shows Importance Of Seeking Treatment Early
News | Heart Valve Technology | August 12, 2020
August 12, 2020 — A national survey conducted by the patient advocacy group...